The 20 Best POEMS Syndrome Doctors Near Me in Ann Arbor, MI

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

Dr. Pettit studied physics and magazine journalism at Syracuse University prior to earning her MD from the Chicago Medical School. She went on to complete her residency in internal medicine and fellowships in hematology/oncology and clinical pharmacology/pharmacogenomics at the University of Chicago. She has received national recognition for her research, including the Conquer Cancer Foundation/ASCO Young Investigator Award, the ASCPT Presidential Trainee Award, and selection for the ASH Clinical Research Training Institute. Dr. Pettit focuses on translational research and drug development for patients with myeloid malignancies, specifically myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. Dr. Pettit is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Splenectomy. Dr. Pettit is board certified in Medical Oncology and Hematology.

Dr. Carty completed her undergraduate work at Harvard University, graduating magna cum laude, with a degree in Biochemical Sciences. She attended the Albert Einstein College of Medicine in New York where she earned her MD degree. Dr. Carty stayed in New York for her internal medicine residency at Columbia University Medical Center, and moved to the Hospital of the University of Pennsylvania for her Hematology-Oncology fellowship. She remained on staff at the Hospital of the University of Pennsylvania before moving here to Ann Arbor. Dr. Carty is the recipient of a K08 Award for her work in T cell biology and ASH Scholar Award for her research on T cell lymphomas. Dr. Carty is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Carty is board certified in Hematology.

Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology.

Mark Kaminski is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Kaminski is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Gastric Lymphoma, and Bone Marrow Aspiration.

Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration. Dr. Karimi is board certified in Internal Medicine, Hematology, and Medical Oncology.

Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Internal Medicine and Hematology.

Dr. Talpaz comes to U-M from the University of Texas M.D. Anderson Cancer Center in Houston, where he was a professor of medicine. His research interests include the study of leukemia and immunotherapy, which uses the immune system to fight cancer. He also treats patients with leukemia. Talpaz will continue his research, expanding the U-M Rogel Cancer Center's efforts in hematologic cancer. He will serve as professor of internal medicine at the U-M Medical School. Dr. Talpaz is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Chronic Myelogenous Leukemia (CML), Myeloproliferative Neoplasms (MPN), and Polycythemia Vera. Dr. Talpaz is board certified in Internal Medicine and Medical Oncology.

Languages: English, Spanish Activities: Running, Cycling. Awards:2023 Castle Connolly Top Doctor. Dr. Pianko is rated as an Experienced provider by MediFind in the treatment of POEMS Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, and Bone Marrow Transplant. Dr. Pianko is board certified in Internal Medicine, Hematology, and Medical Oncology.